Our experiments further demonstrated that inhibiting the xCT-GSH-GPX4 pathway can synergistically enhance disulfiram/copper (DSF/Cu)-induced cuproptosis in myelodysplastic syndrome [191]. This evidence concerns the gene GPX4 and myelodysplastic syndrome.